The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease

CJ Van der Woude, S Ardizzone… - Journal of Crohn's …, 2015 - academic.oup.com
Trying to conceive and being pregnant is an emotional period for those involved. In the
majority of patients suffering from inflammatory bowel disease, maintenance therapy is …

[HTML][HTML] Crohn's disease

DC Baumgart, WJ Sandborn - The Lancet, 2012 - thelancet.com
Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the
gastrointestinal tract with extraintestinal manifestations and associated immune disorders …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

A Dignass, R Eliakim, F Magro, C Maaser… - Journal of Crohn's …, 2012 - academic.oup.com
Ulcerative colitis is a lifelong disease arising from an interaction between genetic and
environmental factors, observed predominantly in the developed countries of the world. The …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

A Dignass, JO Lindsay, A Sturm… - Journal of Crohn's …, 2012 - academic.oup.com
When deciding the appropriate treatment strategy for active ulcerative colitis one should
consider the activity, distribution (proctitis, left-sided, extensive 1), and pattern of disease …

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

J Burisch, N Pedersen, S Čuković-Čavka, M Brinar… - Gut, 2014 - gut.bmj.com
Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern
Europe. The reasons for these changes remain unknown. The aim of this study was to …

Outcomes of pregnancies with maternal/paternal exposure in the tofacitinib safety databases for ulcerative colitis

U Mahadevan, MC Dubinsky, C Su… - Inflammatory bowel …, 2018 - academic.oup.com
Background Active inflammatory bowel disease increases the risk of adverse pregnancy
outcomes. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of …

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease

MJ Casanova, M Chaparro, E Domenech… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: The safety of thiopurines and anti-tumor necrosis factor-α (TNF-α) drugs
during pregnancy remains controversial, as the experience with these drugs in this situation …

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women

N Pedersen, A Bortoli, D Duricova… - Alimentary …, 2013 - Wiley Online Library
Background The impact of pregnancy on the course of IBD is still controversial. Aim To
investigate the impact of pregnancy on IBD and to search for factors with potential impact on …

Preconception care reduces relapse of inflammatory bowel disease during pregnancy

A de Lima, Z Zelinkova, AG Mulders… - Clinical …, 2016 - Elsevier
Background & Aims Women with inflammatory bowel disease (IBD) may have incorrect
beliefs about their disease and its medication in relation to pregnancy. We studied the …

Pregnancy outcome after TNF‐α inhibitor therapy during the first trimester: a prospective multicentre cohort study

C Weber‐Schoendorfer, M Oppermann… - British journal of …, 2015 - Wiley Online Library
Aims TNF‐α inhibitors are considered relatively safe in pregnancy but experience is still
limited. The aim of this study was to evaluate the risk of major birth defects, spontaneous …